Abstract:
Background: Cannabis-containing medicines have been successfully used in our practice for more than 20 years in pain and especially in geriatric and palliative patients. While it was initially a very indication-specific use (pain, loss of appetite, etc.) and also with higher THC doses, this changed over time to low THC doses and a therapy focus on suffering-perpetuating symptoms and especially on stress (Matrix of Symptoms).
Method: As part of the legally prescribed companion survey, we evaluated our data in parallel and discussed it publicly in a series of publications. Based on these published results, the article is intended to show an overview of our experiences.
Results: Low-dose THC has a positive effect on morbidity, side effects, quality of life and mortality in geriatric and palliative patients.
Conclusion: Early therapy is particularly appropriate in geriatric and palliative patients due to the clear benefit-risk ratio of low-dose THC.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Dr. med. Knud Gastmeier ist stellvertretender Sprecher der Ad-hoc-Kommission Cannabis der Deutschen Schmerzgesellschaft e. V. und Leiter der AG Cannabis des BVSD. Er erhielt Honorare für Vorträge bzw. Beratertätigkeit für Bionorica ethic GmbH, Kyowa Kirin GmbH, Aurora Deutschland Gmbh, Tilray Deutschland GmbH, Sanity Group & Vayamed, Cannamedical Pharma GmbH, Stada GmbH.
Dr. med. Anne Gastmeier erhielt von der Firma Stada GmbH Vortragshonorare.
Supplementary Information
Rights and permissions
About this article
Cite this article
Gastmeier, K., Gastmeier, A. Niedrig dosiertes THC in der Geriatrie und Palliativmedizin. MMW - Fortschritte der Medizin 164 (Suppl 5), 10–14 (2022). https://doi.org/10.1007/s15006-022-1856-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-022-1856-1